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Introduction 
Neurological manifestations of sarcoidosis can be the presenting feature of the disease 
and are reported to be present in up to 15% of patients with systemic sarcoidosis (1). The 
most common neurological manifestation is cranial nerve palsy with a special propensity 
for the facial nerve (1). Almost half of the patients have symptoms of parenchymal 
affection which is demonstrated as encephalopathy, mass effect or hypothalamic disorder 
(1).  
We present a patient with progressive meningoencephalitis and diffuse brain MRI 
abnormalities due to neurosarcoidosis. 
 
Case report 
A 38-year-old woman was referred to our hospital because of a progressive neurological 
decline. Her first symptom was an unexplained fever that started four months prior. 
Pneumonia was suspected but the fever persisted despite introduction of two different 
antibiotics. There were no other general signs. A month later she was first seen by a 
neurologist because of a left peripheral facial palsy. During the following months she 
developed bilateral facial palsy, her hearing became impaired and walking was becoming 
increasingly strenuous. On admission, examination revealed spastic tetraparesis with 
more severe affection of the legs. Her speech was dysarthric. She wasn’t able to protrude 
her tongue. Bilateral palatal muscle paresis was present and she had difficulty 
swallowing. Brain MRI showed diffuse T2 and FLAIR hyperintensity of the 
periventricular and deep white matter. Symmetrical hyperintensity in the deincephalic-
mesencephalic boundary, tegmentum of the pons, middle cerebellar peduncle and hylus 
of the nucleus dentatus was visible (Figure 1). The MRI of the cervical spinal cord was 
normal. MR spectroscopy showed increased Choline in the frontal regions and reduced 
NAA in the parietal region (Figure 2). MR angiography was normal. Sedimentation rate 
was elevated (26 mm/h), leukocytes, C reactive protein, liver enzymes and B12 level 
were within normal limits. Serum calcium levels were 2.06 mmol/l and calcium in the 24 
h urine was 7.88 mmol/dU. Serum angiotensin-converting enzyme level was raised to 74 
U/L. Cerebrospinal fluid analysis revealed 53 cells per cubic milliter, 99% of them being 
lymphocytes, a protein level of 1.13 g/l, CSF glucose of 2.2 mmol/l and oligoclonal IgG 
bands were negative. Extensive serological investigation (including serology for 
brucellosis, toxoplasmosis, borreliosis, EBV, CMV, HHV6, VZV, WNF, and JCV PCR), 
bacterial and tuberculosis cultures and Quantiferon test were negative. The results of the 
bone marrow aspiration were normal. Arylsulfatase A, very long chain fatty acid and 
GFAP genetic analysis were normal. Chest CT demonstrated multiple enlarged lymph 
nodes bilaterally in middle and lower mediastinum. Fiberoptic bronchoscopy was done 
with biopsy of the enlarged lymph nodes, which showed noncaseating epithelioid 
granulomas. Whole body 
67
gallium scan showed bilateral hilar lymphadenopathy uptake 
with lacrimal and parotid gland uptake. The patient was diagnosed with neurosarcoidosis 
and she was treated with methylprednisolone and cyclophosphamide. She showed gradual 
improvement on follow-up six months later and significant resolution of diffuse MRI 
lesions. 
 
 
 
Discussion 
Our patient was diagnosed as “probable” neurosarcoidosis according to the accepted 
criteria (suggestive symptoms, positive findings on extra-CNS biopsy, laboratory results 
of CNS inflammation, exclusion of other diseases). 
The differential diagnosis in presented patient is comprehensive. Tuberculosis was 
excluded with negatice CSF cultures and Quantiferon test. Histiocytosis of Langerhans 
and non Langerhans type (Ercheim-Chester disease) were considered, however the 
absence of bone lesions and normal bone marrow argued against these diagnoses. 
Leukodystophies or other toxic and metabolic causes were excluded with appropriate 
tests. 
MRI can detect neurological lesions in 10% of patients with sarcoidosis and is the 
imaging modality of choice in the diagnosis and follow-up of nervous involvement of 
sarcoidosis.(1) The pathologic hallmark are leptomeningeal inflammation or parenchymal 
findings in a form of mass lesions or granulomas.(2) While the intraparenchymal T2 
hyperintense lesions are the most common finding on brain MRI there are several 
characteristic MRI patterns that can help us in the diagnosis of neurosarcoidosis.(3) These 
include: 1) periventricular and white matter lesions on T2 sequences, mimicking multiple 
sclerosis, 2) single or multiple supratentorial and infratentorial brain lesions with various 
amounts of vasogenic edema, mimicking tumors and 3) leptomeningeal and ependymal 
enhancement usually in the basal, hypothalamic and periventricular regions. (4) Difusse 
involvement of the brain parenchyma is rarely observed in neurosarcoidosis, and when 
present can pose a diagnostic difficulty. We performed MR spectroscopy of the diffuse 
T2 hyperintensity in our patient on two locations but gained contrary results. NAA is a 
neuronal marker and decreases with any disease that adversely affects neuronal integrity, 
while Choline is a measure of increased cellular turnover and is elevated in tumors and 
inflammatory processes. Therefore these findings were of limited value in presented case 
and systematyc studies on MR spectroscopy in neurosarcoidosis are lacking. Other 
imaging possibility is FDG-PET which was shown helpful in one case.(5) 
Conclusion 
In conclusion, altough T2-hyperintense white matter lesions are not uncommon they are 
rarely diffuse and found bilaterally in brainstem as presented here. This report further 
broadens MRI spectrum of neurosarcoidosis. 
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Figures 
 
Figure 1.  
Brain MRI, a,b,c) T2 sequences and d,e,f) FLAIR sequences showing diffuse 
hyperintensity of the periventricular and deep white matter. Symmetrical hyperintensity 
in the deincephalic-mesencephalic boundary, tegmentum of the pons, middle cerebellar 
peduncle and hylus of the nucleus dentatus is seen. There is no postcontrast enhancement. 
 
 
 
 
 
Figure 2.  
MRI spectroscopy in the deep white matter showing a) increased Choline in the frontal 
regions and b) reduced NAA in the parietal region. 
 
 
